The FTSE 100 index lost just 0.29 points at 8,822.91. The FTSE 250 ended down 145.24 points, 0.7%, at 21,557.34, and the AIM All-Share closed down 2.76 points, 0.4%, at 773.49.

(Alliance News) - Henry Boot PLC on Friday said that HBD, the group's property investment and development arm, has secured outline planning consent for phase one of Golden Valley, Cheltenham.

(Alliance News) - Versarien PLC on Friday said it has extended its commercial agreements with Montana Quimica LTDA, a South American manufacturing partner, to expand the use of its graphene-based ...

The pound was quoted down at USD1.3650 at midday on Friday in London, compared to USD1.3654 at the equities close on Thursday. The euro stood higher at USD1.778, against USD1.1762. Against the yen, ...

Huddled Group PLC on Friday announced a new partnership with e-commerce platform THG Ingenuity and a GBP1.5 million investment offer from Shard Capital Partners LPP, as it looks to accelerate growth ...

(Alliance News) - Good Life Plus PLC on Friday announced it intends to withdraw its shares from the Aquis Stock Exchange in London as it posted an increased loss.

(Sharecast News) - London stocks were still weaker by midday on Friday as Donald Trump's 9 July tariff deadline loomed, with trade expected to remain quiet as US markets will be closed for ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Back in June, Rosebank confirmed plans to raise GBP1.14 billion via institutional and private placements priced at 300 pence per share. This was in addition to a EUR8 million open offer, and new loans ...

Battery electric car purchases climbed 39% to 47,354 units in June from 34,034 a year prior, lifting EV market share to just under 25%. SMMT noted that this is still below UK government-mandated ...

RBC raises TT Electronics price target to 120 (85) pence - 'sector perform' Deutsche Bank Research raises Ryanair price target to 27.50 (27) EUR - 'buy' Deutsche Bank Research raises Capita price ...

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer.